PVLA PALVELLA THERAPEUTICS, INC.
Price Chart
Executive Summary
Two insiders at Palvella Therapeutics, Inc. (PVLA) made open-market purchases totaling $800,000 within the past week, buying shares at $125 per share. The transactions represent a coordinated buying signal from corporate insiders, which may reflect confidence in the company's near-term prospects.
Key Financial Metrics
Actionable Insight
Traders should view this coordinated insider buying as a positive signal, particularly given the material dollar amount and open-market nature of the trades. Consider positioning ahead of potential positive catalysts, such as clinical updates or earnings.
Key Facts
- George M. Jenkins purchased 4,000 shares at $125 per share for a total of $500,000 in an open-market transaction.
- Elaine J. Heron purchased 2,400 shares at $125 per share for a total of $300,000 in an open-market transaction.
- Both transactions occurred on 2026-02-27 and were executed in the open market (Form 4 code 'P').
- Total value of the insider cluster: $800,000.
- Cluster represents 0.05% of the company's $1.6B market cap.
Financial Impact
$800,000 in insider buying at $125 per share
Risk Factors
- The total value ($800K) is still relatively small compared to the $1.6B market cap, limiting broad market impact.
- No additional context (e.g., upcoming earnings, clinical data) is provided to confirm the trigger for the buying.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-PVLA-1772456485987 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 15, 2026
8d ago
|
8-K
| — | awaiting T+5 | — | — |
|
May 15, 2026
8d ago
|
Press Release
| — | awaiting T+5 | — | — |
|
May 13, 2026
10d ago
|
8-K
| $120.57 $109.20 | ▼ −9.43% | ▼ −8.27% | $113.99 (−5.46%) |
|
May 7, 2026
16d ago
|
8-K
| $113.26 $120.57 | ▼ −6.45% | ▼ −4.95% | $113.99 (−0.64%) |
|
Apr 30, 2026
23d ago
|
Press Release
| — | awaiting T+5 | — | — |
|
Apr 13, 2026
5w ago
|
8-K
| $129.00 $129.33 | ▲ +0.26% | ▼ −3.04% | $113.99 (−11.64%) |
|
Mar 31, 2026
7w ago
|
8-K
| $124.65 $123.17 | ▼ −1.19% | ▼ −5.13% | $113.99 (−8.55%) |
|
Mar 31, 2026
7w ago
|
Press Release
| $124.65 $123.17 | ▼ −1.19% | ▼ −5.13% | $113.99 (−8.55%) |
|
Mar 27, 2026
8w ago
|
Press Release
| $112.37 $119.86 | ▲ +6.67% | ▲ +2.80% | $113.99 (+1.44%) |
|
Mar 24, 2026
8w ago
|
Press Release
| $116.23 $124.65 | ▲ +7.24% | ▲ +7.67% | $113.99 (−1.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access